Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brit Mollenhauer

Showing results (181-190 of 304) with videos related to

Pageof 31
Sort By:
NPJ Parkinson'S Disease|February 28, 2023
LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohortsKalpana M Merchant, Tanya Simuni, Janel Fedler, et al.
Nature|March 15, 2019
Publisher Correction: β-Synuclein-reactive T cells induce autoimmune CNS grey matter degenerationDmitri Lodygin, Moritz Hermann, Nils Schweingruber, et al.
Journal of Neurochemistry|August 7, 2012
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathiesConnie Luk, Yaroslau Compta, Nadia Magdalinou, et al.
Annals of Neurology|April 22, 2026
Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMICraig E Stanley, Kimberly Fabrizio, Bridget A McMahon, et al.
Genes|December 24, 2021
Validity and Prognostic Value of a Polygenic Risk Score for Parkinson's DiseaseSebastian Koch, Björn-Hergen Laabs, Meike Kasten, et al.
Biomarkers in Medicine|August 25, 2012
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an updateMarta del Campo, Brit Mollenhauer, Antonio Bertolotto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2019
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's diseaseBrit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.
Nature Aging|April 28, 2023
Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson's disease progressionFabian Kern, Tobias Fehlmann, Ivo Violich, et al.
Nature Communications|June 18, 2024
Plasma proteomics identify biomarkers predicting Parkinson's disease up to 7 years before symptom onsetJenny Hällqvist, Michael Bartl, Mohammed Dakna, et al.
NPJ Parkinson'S Disease|July 18, 2025
Identifying individuals at-risk of developing Parkinson's disease using a population-based recruitment strategy: The Healthy Brain Ageing Kassel StudySebastian Schade, Soumyabrata Ghosh, Alicia Garrido, et al.
Pageof 31

Showing results (181-190 of 304) with videos related to

Sort By:
Pageof 31
NPJ Parkinson'S Disease|February 28, 2023
LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohortsKalpana M Merchant, Tanya Simuni, Janel Fedler, et al.
Nature|March 15, 2019
Publisher Correction: β-Synuclein-reactive T cells induce autoimmune CNS grey matter degenerationDmitri Lodygin, Moritz Hermann, Nils Schweingruber, et al.
Journal of Neurochemistry|August 7, 2012
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathiesConnie Luk, Yaroslau Compta, Nadia Magdalinou, et al.
Annals of Neurology|April 22, 2026
Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMICraig E Stanley, Kimberly Fabrizio, Bridget A McMahon, et al.
Genes|December 24, 2021
Validity and Prognostic Value of a Polygenic Risk Score for Parkinson's DiseaseSebastian Koch, Björn-Hergen Laabs, Meike Kasten, et al.
Biomarkers in Medicine|August 25, 2012
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an updateMarta del Campo, Brit Mollenhauer, Antonio Bertolotto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2019
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's diseaseBrit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.
Nature Aging|April 28, 2023
Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson's disease progressionFabian Kern, Tobias Fehlmann, Ivo Violich, et al.
Nature Communications|June 18, 2024
Plasma proteomics identify biomarkers predicting Parkinson's disease up to 7 years before symptom onsetJenny Hällqvist, Michael Bartl, Mohammed Dakna, et al.
NPJ Parkinson'S Disease|July 18, 2025
Identifying individuals at-risk of developing Parkinson's disease using a population-based recruitment strategy: The Healthy Brain Ageing Kassel StudySebastian Schade, Soumyabrata Ghosh, Alicia Garrido, et al.
Pageof 31